The bioavailability of Israeli quinidine preparations
Farfel, Z.; Levi, A.; Millman, P.; Tamari, I.; Halkin, H.
Harefuah 93(7-8): 207-208
1977
ISSN/ISBN: 0017-7768 PMID: 924255 Document Number: 119356
Document emailed within 1 workday
Related Documents
Smith, T.C.; Kinkel, A.W. 1977: Bioavailability of two brands of quinidine gluconate administered on a multiple-dose regimen Current Therapeutic Research 21(1): 128-134Szyszka, A.; Kaźmierczak, E.; Dziegielewska, G.; Lowicki, Z.; Mrozikewicz, A. 1994: Assessment of bioavailability of magnesium preparations Wiadomosci Lekarskie 47(13-14): 481-483
Zak, A.F. 1977: Bioavailability of peroral antibiotic preparations Antibiotiki 22(3): 265-279
Firoz, M.; Graber, M. 2001: Bioavailability of US commercial magnesium preparations Magnesium Research 14(4): 257-262
Bron, J.; Vree, T.B.; Damsma, J.E.; Hekster, Y.A.; van der Kleijn, E. 1979: Dissolution, bioavailability and pharmacokinetics of three nitrofuratoin preparations in man Arzneimittel-Forschung 29(10): 1614-1620
Gupta, K.C.; Paul, T.; Mehta, J.M.; Desai, N.K.; Sanghvi, B.; Sheth, U.K. 1976: Study of bioavailability of oral iron preparations Journal of Postgraduate Medicine 22(2): 94-99
Gastauer, R.; Eltze, M.; Pabst, J. 1979: Bioavailability and elimination of various digoxin preparations in the beagle dog and their possible sex dependence Arzneimittel-Forschung 29(5): 754-757
Warneke, G.; Setnikar, I. 1993: Bioavailability and pharmacokinetics of fluoride from two glutamine monofluorophosphate preparations Arzneimittel-Forschung 43(5): 584-590
Molinaro, M.; Villani, P.; Buggia, I.; Iacona, I.; Zoia, C.; Regazzi, M.B.; Rondanelli, R. 1992: The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations Bollettino Chimico Farmaceutico 131(10): 375-379
Molinaro, M.; Villani, P.; Buggia, I.; Iacona, I.; Zoia, C.; Regazzi, M.B.; Rondanelli, R. 1992: The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations Bollettino Chimico Farmaceutico 131(10): 375-379
Perlík, F.; Janku, I.; Kordac, V. 1988: The effect of guaiphenesin on absorption and bioavailability of paracetamol from composite analgesic preparations International Journal of Clinical Pharmacology Therapy and Toxicology 26(8): 413-416
Simoni, P.; Sabatini, L.; Baraldini, M.; Mirasoli, M.; Roda, A.; Roda, E. 2002: Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration International Journal of Clinical Pharmacology Research 22(2): 37-45
Terhaag, B.; Donath, F.; Le Petit, G.; Feller, K. 1986: The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro-in vivo comparison International Journal of Clinical Pharmacology Therapy and Toxicology 24(6): 298-302
Teekachunhatean, S.; Rojanastein, N.; Manorot, M.; Sangdee, C.; Apisariyakul, A.; Ajayutphokin, U. 1998: The comparative bioavailability of a generic and the innovator fluconazole preparations in healthy Thai volunteers Journal of the Medical Association of Thailand 81(10): 772-778
Alighieri, T.; Avanessian, S.; Berlini, S.; Bianchi, S.G.; Deluigi, P.; Valducci, R.; Guelen, P.J. 1988: Bioavailability of ambroxol sustained release preparations. Part I: In vitro dissolution studies Arzneimittel-Forschung 38(1): 92-94
Janssen, T.J.; Guelen, P.J.; Vree, T.B.; Botterblom, M.H.; Valducci, R. 1988: Bioavailability of ambroxol sustained release preparations. Part II: Single and multiple oral dose studies in man Arzneimittel-Forschung 38(1): 95-97
Woodford, R.; Barry, B.W. 1974: Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay Current Therapeutic Research 16(4): 338-345
Belmaker, R.H. 2012: Successful cultural change: the example of female circumcision among Israeli Bedouins and Israeli Jews from Ethiopia Israel Journal of Psychiatry and Related Sciences 49(3): 178-183
Wemhöner, S.; Oellerich, M.; Sybrecht, G. 1981: Theophylline therapy in obstructive respiratory diseases. 1. Bioavailability and pharmacokinetics of various theophylline preparations Praxis und Klinik der Pneumologie 35(1): 36-41
Lutz, D.; Pabst, G.; Dahmen, W.; Molz, K.H.; Jaeger, H. 1985: Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets Arzneimittel-Forschung 35(12): 1840-1842